Retraction

MicroRNA-218 inhibits proliferation and invasion in ovarian cancer by targeting Runx2

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.18632/oncotarget.28253
Additional Notes:

see also: https://pubpeer.com/publications/B7AADC0A7DB3067FFFFF1E6DE51883

Citations (29)

29
Total Citations
3
Post-Retraction
(10.3%)
26
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
0 After 2+ years
501 Days since retraction (latest)
Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial–mesenchymal transition and angiogenesis in triple-negative breast cancer cells
Samaneh Shojaei, Maryam Moradi‐Chaleshtori, Mahdi Paryan et al. (6 authors)
European journal of medical research Open Access
Published: Nov 2023
19 citations
501 days after retraction
miR-23b-3p, miR-124-3p and miR-218-5p Synergistic or Additive Effects on Cellular Processes That Modulate Cervical Cancer Progression? A Molecular Balance That Needs Attention
Manuel Joaquín Romero-López, Hilda Jiménez‐Wences, Merlin Itsel Cruz-De la Rosa et al. (5 authors)
International Journal of Molecular Sciences Open Access
Published: Nov 2022
7 citations
125 days after retraction
Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial–mesenchymal transition and angiogenesis in triple negative breast cancer cells
Samaneh Shojaei, Maryam Moradi‐Chaleshtori, Mahdi Paryan et al. (6 authors)
Research Square (Research Square) Open Access
Published: Oct 2022
101 days after retraction
miR-218-5p/RUNX2 Axis Positively Regulates Proliferation and Is Associated with Poor Prognosis in Cervical Cancer
Merlin Itsel Cruz-De la Rosa, Hilda Jiménez‐Wences, Judit Alarcón‐Millán et al. (7 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2022
12 citations
9 days before retraction
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Doxorubicin and Topotecan Resistant Ovarian Cancer Cell Lines
Piotr Stasiak, Dominika KaĹşmierczak, Karol Jopek et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: May 2022
12 citations
40 days before retraction
A Translational Model to Improve Early Detection of Epithelial Ovarian Cancers
Allison Gockley, Konrad Pagacz, Stephen Fiascone et al. (10 authors)
Frontiers in Oncology Open Access
Published: Apr 2022
6 citations
72 days before retraction
The Profile of MicroRNA Expression and Potential Role in the Regulation of Drug-Resistant Genes in Cisplatin- and Paclitaxel-Resistant Ovarian Cancer Cell Lines
Dominika Kaźmierczak, Karol Jopek, Karolina Sterzyńska et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Jan 2022
20 citations
179 days before retraction
Evaluating the Role of RUNX2 in Cancer and Its Potential as a Therapeutic Target
Rachael Pulica, Karine Cohen-Solal, Ahmed Lasfar
Springer eBooks
Published: Jan 2022
1 citation
182 days before retraction
MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2 (Runx2) in human osteosarcoma cells
Qiang Guo, Jun‐An Ma, Jing Wu
Regenerative Therapy Open Access
Published: Dec 2021
8 citations
213 days before retraction
MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer
Yegane Mirahmadi, Reza Nabavi, Fourough Taheri et al. (11 authors)
Journal of Oncology Open Access
Published: Oct 2021
21 citations
254 days before retraction
Rab6c is a new target of miR‑218 that can promote the progression of bladder cancer
Long He, Xiang Pan, Xialu Wang et al. (7 authors)
Molecular Medicine Reports Open Access
Published: Sep 2021
3 citations
295 days before retraction
The Role of microRNAs in Epithelial Ovarian Cancer Metastasis
Vu H. Nguyen, Chenyang Yue, Kevin Y. Du et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Sep 2020
39 citations
645 days before retraction
<p>MiR-218-5p Suppresses the Progression of Retinoblastoma Through Targeting NACC1 and Inhibiting the AKT/mTOR Signaling Pathway</p>
Li Li, Hua Yu, Qian Ren
Cancer Management and Research Open Access
Published: Aug 2020
18 citations
700 days before retraction
miRNA profile in ovarian cancer
Soudeh Ghafouri‐Fard, Hamed Shoorei, Mohammad Taheri
Experimental and Molecular Pathology
Published: Jan 2020
114 citations
898 days before retraction
Role of microRNAs as Clinical Cancer Biomarkers for Ovarian Cancer: A Short Overview
Cristina Elena Staicu, Dragoş Predescu, Călin Mircea Rusu et al. (8 authors)
Cells Open Access
Published: Jan 2020
71 citations
905 days before retraction
Inhibition of human cervical cancer cell invasion by IL-37 involving runt related transcription factor 2 suppression
Ping Ouyang, Kun Wu, Liudan Su et al. (13 authors)
Annals of Translational Medicine Open Access
Published: Oct 2019
19 citations
1005 days before retraction
RETRACTED: Downregulation of miR‐218 by nicotine promotes cell proliferation through targeting CDK6 in non–small cell lung cancer
Zhen Liu, Cuiling Lu, Guanren Zhao et al. (8 authors)
Journal of Cellular Biochemistry
Published: Jun 2019
9 citations
1116 days before retraction
Survivin is a prognostic indicator in glioblastoma and may be a target of microRNA‑218
Xuezhi Tong, Pei Yang, Kuanyu Wang et al. (9 authors)
Oncology Letters Open Access
Published: May 2019
33 citations
1152 days before retraction
MiR-591 functions as tumor suppressor in breast cancer by targeting TCF4 and inhibits Hippo-YAP/TAZ signaling pathway
Xin Huang, Fen Tang, Zeping Weng et al. (5 authors)
Cancer Cell International Open Access
Published: Apr 2019
30 citations
1165 days before retraction
A 19‑miRNA Support Vector Machine classifier and a 6‑miRNA risk score system designed for ovarian cancer patients
Jinwei Dong, Mingjun Xu
Oncology Reports Open Access
Published: Apr 2019
24 citations
1179 days before retraction
circEIF4G2 modulates the malignant features of cervical cancer via the miR‑218/HOXA1 pathway
Yifan Mao, Liya Zhang, Yuan Li
Molecular Medicine Reports Open Access
Published: Mar 2019
47 citations
1206 days before retraction
The Differential Expression of miRNAs and a Preliminary Study on the Mechanism of miR-194-3p in Keloids
Zhishan Xu, Bingyu Guo, Peng Chang et al. (6 authors)
BioMed Research International Open Access
Published: Mar 2019
21 citations
1213 days before retraction
MicroRNA‑218 inhibits the cell proliferation and migration in clear cell renal cell carcinoma through targeting cancerous inhibitor of protein phosphatase 2A
Ruojing Wei, Xiongjun Ye, Yawei Zhao et al. (9 authors)
Oncology Letters Open Access
Published: Jan 2019
9 citations
1250 days before retraction
Promoting dentinogenesis of DPSCs through inhibiting microRNA-218 by using magnetic nanocarrier delivery
Karen Chang, Rung‐Shu Chen, Fu‐Hsiung Chang et al. (4 authors)
Journal of the Formosan Medical Association Open Access
Published: Nov 2018
19 citations
1318 days before retraction
MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14
Hongbin Zhang, Xiaoqun Zhang, Jun Zhang
Biochemical and Biophysical Research Communications
Published: Oct 2018
53 citations
1351 days before retraction
MiR‐218 regulated cardiomyocyte differentiation and migration in mouse embryonic stem cells by targeting PDGFRα
Tingting Xu, Nuoya Liu, Ying Shao et al. (5 authors)
Journal of Cellular Biochemistry
Published: Sep 2018
9 citations
1378 days before retraction
Association between miR-218 rs11134527 polymorphism and risk of selected types of cancer in Asian population: An updated meta-analysis of case-control studies
Abdolkarim Moazeni‐Roodi, Gholamreza Bahari, Mohsen Taheri et al. (5 authors)
Gene
Published: Aug 2018
3 citations
1416 days before retraction
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
Haihai Liang, Tong Yu, Yue Han et al. (12 authors)
Molecular Cancer Open Access
Published: Aug 2018
312 citations
1421 days before retraction
Prognostic Role of MicroRNA-497 In Cancer Patients: A Meta-analysis
Jiaxi Feng, Xi Gu, Liyang Liu et al. (9 authors)
Journal of Cancer Open Access
Published: Jan 2018
9 citations
1643 days before retraction
Quick Stats
Total Citations: 29
Years Since Retraction: 3.4 years
Open Access: Yes
Last Checked: Jul 24, 2025